1 1789 134 PRELIMINARY INDICATIONS OF THE EFFECT OF A BRIEF YOGA INTERVENTION ON MARKERS OF INFLAMMATION AND DNA METHYLATION IN CHRONICALLY STRESSED WOMEN. YOGA IS ASSOCIATED WITH REDUCED STRESS AND INCREASED WELL-BEING, ALTHOUGH THE MOLECULAR BASIS FOR THESE BENEFITS IS NOT CLEAR. MOUNTING EVIDENCE IMPLICATES THE IMMUNE RESPONSE, WITH CURRENT STUDIES FOCUSED ON PROTEIN IMMUNE MARKERS (SUCH AS CYTOKINES) IN CLINICAL POPULATIONS. TO EXPLORE THE MOLECULAR IMPACT, THIS PILOT STUDY USES A SUBSAMPLE (N=28) FROM A RANDOMISED WAITLIST CONTROL TRIAL INVESTIGATING THE IMPACT OF AN 8-WEEK YOGA INTERVENTION IN A COMMUNITY POPULATION OF WOMEN REPORTING PSYCHOLOGICAL DISTRESS (N=116). WE MEASURED INTERLEUKIN-6 (IL-6), TUMOUR NECROSIS FACTOR (TNF) AND C-REACTIVE PROTEIN (CRP) PROTEIN LEVELS, AND THE DNA METHYLATION OF THESE GENES AND THE GLOBAL INDICATOR, LINE-1. CORRELATIONS BETWEEN THESE AND PSYCHOLOGICAL VARIABLES WERE EXPLORED, IDENTIFYING MODERATE CORRELATIONS WITH CRP PROTEIN LEVELS, AND METHYLATION OF IL-6, CRP AND LINE-1. MANY CYTOKINE SAMPLES WERE BELOW DETECTION, HOWEVER A MANN-WHITNEY U DEMONSTRATED A TREND OF MODERATE BETWEEN-GROUP EFFECT FOR ELEVATED IL-6 IN THE YOGA GROUP. METHYLATION ANALYSES APPLIED CROSS-SECTIONAL AND NON-CONTROLLED LONGITUDINAL ANALYSES. WAIST-TO-HEIGHT RATIO AND AGE WERE COVARIED. WE DEMONSTRATED REDUCED METHYLATION OF THE TNF REGION IN THE YOGA GROUP RELATIVE TO THE WAITLIST CONTROL GROUP. NO OTHER GENES DEMONSTRATED A SIGNIFICANT DIFFERENCE. LONGITUDINAL ANALYSIS FURTHER SUPPORTED THESE RESULTS. THIS STUDY IS ONE OF THE FIRST TO EXPLORE YOGA AND IMMUNOLOGICAL MARKERS IN A NON-CLINICAL POPULATION, AND IS THE FIRST STUDY TO EXPLORE DNA METHYLATION. THESE FINDINGS INDICATE THAT FURTHER RESEARCH INTO MOLECULAR IMPACT OF YOGA ON MARKERS OF IMMUNE FUNCTION IS WARRANTED, WITH LARGER STUDIES REQUIRED. 2016 2 392 46 BENEFITS OF YOGA ON IL-6: FINDINGS FROM A RANDOMIZED CONTROLLED TRIAL OF YOGA FOR DEPRESSION. THE PRESENT RESEARCH SOUGHT TO EXAMINE WHETHER HATHA YOGA, IMPLEMENTED AS AN ADJUNCTIVE INTERVENTION FOR MAJOR DEPRESSION, INFLUENCES MARKERS OF INFLAMMATION. A SUBSET OF 84 PARTICIPANTS WHO WERE ENROLLED IN A RANDOMIZED CONTROLLED TRIAL (RCT) OF HATHA YOGA VS. HEALTH EDUCATION CONTROL PROVIDED BLOOD SAMPLES AT BASELINE (PRE-TREATMENT) AND AT 3-(DURING TREATMENT) AND 10-WEEK (END OF TREATMENT) FOLLOW-UP VISITS. TO BE ELIGIBLE FOR THE RCT, PARTICIPANTS MET CRITERIA FOR A CURRENT OR RECENT (PAST TWO YEARS) MAJOR DEPRESSIVE EPISODE, HAD CURRENT ELEVATED DEPRESSION SYMPTOMS, AND CURRENT ANTIDEPRESSANT MEDICATION USE. VENOUS BLOOD WAS DRAWN BETWEEN 2 AND 6 PM AND FOLLOWING AT LEAST ONE HOUR OF FASTING, AND INFLAMMATORY MARKERS (IL-6, CRP, AND TNF-ALPHA) WERE ASSAYED. EFFECTS OF PARTICIPATION IN YOGA RELATIVE TO HEALTH EDUCATION ON INFLAMMATORY MARKERS OVER TIME WERE EXAMINED WITH LATENT GROWTH ANALYSES. WE OBSERVED A SIGNIFICANT REDUCTION IN IL-6 CONCENTRATIONS IN THE YOGA TREATMENT GROUP RELATIVE TO THE HEALTH EDUCATION CONTROL GROUP AS DEMONSTRATED BY A NEGATIVE INTERACTION BETWEEN TREATMENT GROUP AND SLOPE OF IL-6. TNF-ALPHA AND CRP DID NOT EVIDENCE SIGNIFICANT INTERACTIONS OF TREATMENT GROUP BY MEAN SLOPE OR INTERCEPT. IN ADDITION TO THE BENEFITS OF HATHA YOGA AS AN ADJUNCTIVE INTERVENTION FOR INDIVIDUALS WHO HAVE SHOWN INADEQUATE RESPONSE TO ANTIDEPRESSANT MEDICATIONS, OUR FINDINGS POINT TO POSSIBLE BENEFITS OF YOGA ON IL-6 IN DEPRESSED POPULATIONS. FURTHER RESEARCH IS NEEDED TO EXPLORE THE EFFECTS OF HATHA YOGA ON IMMUNE FUNCTION OVER TIME. 2021 3 1407 35 IMPACT OF YOGA ON INFLAMMATORY BIOMARKERS: A SYSTEMATIC REVIEW. BACKGROUND: MANY CHRONIC CONDITIONS, INCLUDING HEART DISEASE, CANCER, AND RHEUMATOID ARTHRITIS, ARE ASSOCIATED WITH UNDERLYING CHRONIC INFLAMMATORY PROCESSES. LITERATURE REVIEWS HAVE ANALYZED A VARIETY OF INTEGRATIVE THERAPIES AND THEIR RELATIONSHIPS WITH CHRONIC INFLAMMATION. THIS SYSTEMATIC REVIEW IS UNIQUE IN REPORTING SOLELY ON YOGA'S RELATIONSHIP WITH INFLAMMATION. ITS PURPOSE WAS TO SYNTHESIZE CURRENT LITERATURE EXAMINING THE IMPACT OF YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS IN ADULTS WITH CHRONIC INFLAMMATORY-RELATED DISORDERS. METHOD: SEARCHES OF SEVERAL ELECTRONIC DATABASES WERE CONDUCTED. INCLUSION CRITERIA WERE (A) ENGLISH LANGUAGE, (B) SAMPLE AGE >18 YEARS OLD, (C) YOGA INTERVENTIONS INVOLVING POSTURES WITH OR WITHOUT YOGA BREATHING AND/OR MEDITATION, AND (D) MEASURED INFLAMMATORY BIOMARKERS. RESULTS: THE FINAL REVIEW INCLUDED 15 PRIMARY STUDIES. OF THESE, SEVEN WERE RATED AS EXCELLENT AND EIGHT AS AVERAGE OR FAIR. THERE WAS CONSIDERABLE VARIABILITY IN YOGA TYPES, COMPONENTS, FREQUENCY, SESSION LENGTH, INTERVENTION DURATION, AND INTENSITY. THE MOST COMMON BIOMARKERS MEASURED WERE INTERLEUKIN-6 ( N = 11), C-REACTIVE PROTEIN ( N = 10), AND TUMOR NECROSIS FACTOR ( N = 8). MOST STUDIES REPORTED POSITIVE EFFECTS ON INFLAMMATORY BIOMARKERS ( N = 11) FROM BASELINE TO POST YOGA INTERVENTION. ANALYSIS OF THE DOSE SHOWED HIGHER TOTAL DOSE (>1,000 MIN) RESULTED IN GREATER IMPROVEMENTS IN INFLAMMATION. CONCLUSION: THIS REVIEW SUGGESTS THAT YOGA CAN BE A VIABLE INTERVENTION TO REDUCE INFLAMMATION ACROSS A MULTITUDE OF CHRONIC CONDITIONS. FUTURE STUDIES WITH DETAILED DESCRIPTIONS OF YOGA INTERVENTIONS, MEASUREMENT OF NEW AND WELL-ESTABLISHED INFLAMMATORY BIOMARKERS, AND LARGER SAMPLE SIZES ARE WARRANTED TO ADVANCE THE SCIENCE AND CORROBORATE RESULTS. 2019 4 1707 37 PATTERNS OF YOGA PRACTICE AND PHYSICAL ACTIVITY FOLLOWING A YOGA INTERVENTION FOR ADULTS WITH OR AT RISK FOR TYPE 2 DIABETES. BACKGROUND: THE CURRENT STUDY DESCRIBED PATTERNS OF YOGA PRACTICE AND EXAMINED DIFFERENCES IN PHYSICAL ACTIVITY OVER TIME BETWEEN INDIVIDUALS WITH OR AT RISK FOR TYPE 2 DIABETES WHO COMPLETED AN 8-WEEK YOGA INTERVENTION COMPARED WITH CONTROLS. METHODS: A LONGITUDINAL COMPARATIVE DESIGN MEASURED THE EFFECT OF A YOGA INTERVENTION ON YOGA PRACTICE AND PHYSICAL ACTIVITY, USING DATA AT BASELINE AND POSTINTERVENTION MONTHS 3, 6, AND 15. RESULTS: DISPARATE PATTERNS OF YOGA PRACTICE OCCURRED BETWEEN INTERVENTION AND CONTROL PARTICIPANTS OVER TIME, BUT THE SUBJECTIVE DEFINITION OF YOGA PRACTICE LIMITS INTERPRETATION. MULTILEVEL MODEL ESTIMATES INDICATED THAT TREATMENT GROUP DID NOT HAVE A SIGNIFICANT INFLUENCE IN THE RATE OF CHANGE IN PHYSICAL ACTIVITY OVER THE STUDY PERIOD. WHILE AGE AND EDUCATION WERE NOT SIGNIFICANT INDIVIDUAL PREDICTORS, THE INCLUSION OF THESE VARIABLES IN THE MODEL DID IMPROVE FIT. CONCLUSIONS: FINDINGS INDICATE THAT AN 8-WEEK YOGA INTERVENTION HAD LITTLE EFFECT ON PHYSICAL ACTIVITY OVER TIME. FURTHER RESEARCH IS NECESSARY TO EXPLORE THE INFLUENCE OF YOGA ON BEHAVIORAL HEALTH OUTCOMES AMONG INDIVIDUALS WITH OR AT RISK FOR TYPE 2 DIABETES. 2012 5 2768 53 YOGA REDUCES INFLAMMATORY SIGNALING IN FATIGUED BREAST CANCER SURVIVORS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: YOGA IS A POPULAR MIND-BODY THERAPY THAT HAS DEMONSTRATED BENEFICIAL EFFECTS ON PSYCHOLOGICAL, BEHAVIORAL, AND FUNCTIONAL OUTCOMES. HOWEVER, FEW STUDIES HAVE INVESTIGATED EFFECTS ON INFLAMMATORY PROCESSES. THIS STUDY TESTED THE HYPOTHESIS THAT AN IYENGAR YOGA INTERVENTION SPECIFICALLY DESIGNED FOR FATIGUED BREAST CANCER SURVIVORS WOULD LEAD TO DECREASES IN INFLAMMATION-RELATED GENE EXPRESSION AND CIRCULATING MARKERS OF PROINFLAMMATORY CYTOKINE ACTIVITY. METHODS: BREAST CANCER SURVIVORS WITH PERSISTENT CANCER-RELATED FATIGUE WERE RANDOMIZED TO A 12-WEEK IYENGAR YOGA INTERVENTION (N=16) OR A 12-WEEK HEALTH EDUCATION CONTROL CONDITION (N=15). BLOOD SAMPLES WERE COLLECTED AT BASELINE, POST-INTERVENTION, AND AT A 3-MONTH FOLLOW-UP FOR GENOME-WIDE TRANSCRIPTIONAL PROFILING AND BIOINFORMATIC ANALYSES. PLASMA INFLAMMATORY MARKERS AND SALIVARY CORTISOL WERE ALSO ASSESSED. RESULTS: IN PROMOTER-BASED BIOINFORMATICS ANALYSES, THE YOGA GROUP SHOWED REDUCED ACTIVITY OF THE PRO-INFLAMMATORY TRANSCRIPTION FACTOR NUCLEAR FACTOR KAPPA B (NF-KAPPAB), INCREASED ACTIVITY OF THE ANTI-INFLAMMATORY GLUCOCORTICOID RECEPTOR, AND REDUCED ACTIVITY OF CAMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) FAMILY TRANSCRIPTION FACTORS RELATIVE TO CONTROLS (ALL PS<.05). THERE WAS ALSO A SIGNIFICANT INTERVENTION EFFECT ON THE SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TYPE II (STNF-RII), A MARKER OF TNF ACTIVITY; PLASMA LEVELS OF STNF-RII REMAINED STABLE IN THE YOGA GROUP, WHEREAS LEVELS OF THIS MARKER INCREASED IN THE HEALTH EDUCATION GROUP (P=.028). A SIMILAR, NON-SIGNIFICANT TREND WAS OBSERVED FOR THE INTERLEUKIN 1 RECEPTOR ANTAGONIST (P=.16). NO SIGNIFICANT CHANGES IN C REACTIVE PROTEIN (CRP), INTERLEUKIN 6 (IL-6), OR DIURNAL CORTISOL MEASURES WERE OBSERVED. CONCLUSIONS: A 12-WEEK RESTORATIVE IYENGAR YOGA INTERVENTION REDUCED INFLAMMATION-RELATED GENE EXPRESSION IN BREAST CANCER SURVIVORS WITH PERSISTENT FATIGUE. THESE FINDINGS SUGGEST THAT A TARGETED YOGA PROGRAM MAY HAVE BENEFICIAL EFFECTS ON INFLAMMATORY ACTIVITY IN THIS PATIENT POPULATION, WITH POTENTIAL RELEVANCE FOR BEHAVIORAL AND PHYSICAL HEALTH. 2014 6 1424 22 IMPROVEMENT IN PHYSIOLOGICAL AND PSYCHOLOGICAL PARAMETERS AFTER 6 MONTHS OF YOGA PRACTICE. YOGA IS BELIEVED TO HAVE BENEFICIAL EFFECTS ON COGNITION, ATTENUATION OF EMOTIONAL INTENSITY AND STRESS REDUCTION. PREVIOUS STUDIES WERE MAINLY PERFORMED ON EASTERN EXPERIENCED PRACTITIONERS OR UNHEALTHY SUBJECTS UNDERGOING CONCOMITANT CONVENTIONAL THERAPIES. FURTHER INVESTIGATION IS NEEDED ON THE EFFECTS OF YOGA PER SE, AS WELL AS ITS POSSIBLE PREVENTIVE BENEFITS ON HEALTHY SUBJECTS. WE INVESTIGATED THE EFFECTS OF YOGA ON MEMORY AND PSYCHOPHYSIOLOGICAL PARAMETERS RELATED TO STRESS, COMPARING YOGA PRACTICE AND CONVENTIONAL PHYSICAL EXERCISES IN HEALTHY MEN (PREVIOUSLY YOGA-NAIVE). MEMORY TESTS, SALIVARY CORTISOL LEVELS AND STRESS, ANXIETY, AND DEPRESSION INVENTORIES WERE ASSESSED BEFORE AND AFTER 6 MONTHS OF PRACTICE. YOGA PRACTITIONERS SHOWED IMPROVEMENT OF THE MEMORY PERFORMANCE, AS WELL AS IMPROVEMENTS IN PSYCHOPHYSIOLOGICAL PARAMETERS. THE PRESENT RESULTS SUGGEST THAT REGULAR YOGA PRACTICE CAN IMPROVE ASPECTS OF COGNITION AND QUALITY OF LIFE FOR HEALTHY INDIVIDUALS. AN INDIRECT INFLUENCE OF EMOTIONAL STATE ON COGNITIVE IMPROVEMENT PROMOTED BY YOGA PRACTICE CAN BE PROPOSED. 2012 7 2516 20 YOGA CLINICAL RESEARCH REVIEW. IN THIS PAPER RECENT RESEARCH IS REVIEWED ON THE EFFECTS OF YOGA POSES ON PSYCHOLOGICAL CONDITIONS INCLUDING ANXIETY AND DEPRESSION, ON PAIN SYNDROMES, CARDIOVASCULAR, AUTOIMMUNE AND IMMUNE CONDITIONS AND ON PREGNANCY. FURTHER, THE PHYSIOLOGICAL EFFECTS OF YOGA INCLUDING DECREASED HEARTRATE AND BLOOD PRESSURE AND THE PHYSICAL EFFECTS INCLUDING WEIGHT LOSS AND INCREASED MUSCLE STRENGTH ARE REVIEWED. FINALLY, POTENTIAL UNDERLYING MECHANISMS ARE PROPOSED INCLUDING THE STIMULATION OF PRESSURE RECEPTORS LEADING TO ENHANCED VAGAL ACTIVITY AND REDUCED CORTISOL. THE REDUCTION IN CORTISOL, IN TURN, MAY CONTRIBUTE TO POSITIVE EFFECTS SUCH AS ENHANCED IMMUNE FUNCTION AND A LOWER PREMATURITY RATE. 2011 8 784 28 EFFECT OF YOGA BASED LIFESTYLE INTERVENTION ON SUBJECTIVE WELL-BEING. YOGA IS ASSUMING IMPORTANCE IN IMPROVING MENTAL HEALTH AND QUALITY OF LIFE IN THE TREATMENT OF A NUMBER OF PSYCHIATRIC AND PSYCHOSOMATIC DISORDERS. THE PRESENT STUDY WAS A PROSPECTIVE CONTROLLED STUDY TO EXPLORE THE SHORT-TERM IMPACT OF A COMPREHENSIVE BUT BRIEF LIFESTYLE INTERVENTION, BASED ON YOGA, ON SUBJECTIVE WELL BEING LEVELS IN NORMAL AND DISEASED SUBJECTS. NORMAL HEALTHY INDIVIDUALS AND SUBJECTS HAVING HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS OR A VARIETY OF OTHER ILLNESSES WERE INCLUDED IN THE STUDY. THE OUTCOME MEASURES WERE 'SUBJECTIVE WELL BEING INVENTORY' (SUBI) SCORES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. THE INVENTORY CONSISTS OF QUESTIONS RELATED TO ONE'S FEELINGS AND ATTITUDE ABOUT VARIOUS AREAS OF LIFE, SUCH AS HAPPINESS, ACHIEVEMENT AND INTERPERSONAL RELATIONSHIP. THERE WAS SIGNIFICANT IMPROVEMENT IN THE SUBJECTIVE WELL BEING SCORES OF THE 77 SUBJECTS WITHIN A PERIOD OF 10 DAYS AS COMPARED TO CONTROLS. THESE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATIONAL PROGRAM LEADS TO REMARKABLE IMPROVEMENT IN THE SUBJECTIVE WELL BEING SCORES OF THE SUBJECTS AND CAN THEREFORE MAKE AN APPRECIABLE CONTRIBUTION TO PRIMARY PREVENTION AS WELL AS MANAGEMENT OF LIFESTYLE DISEASES. 2008 9 2170 35 THE EFFECTS OF YOGA ON ANXIETY AND STRESS. STRESS AND ANXIETY HAVE BEEN IMPLICATED AS CONTRIBUTORS TO MANY CHRONIC DISEASES AND TO DECREASED QUALITY OF LIFE, EVEN WITH PHARMACOLOGIC TREATMENT. EFFORTS ARE UNDERWAY TO FIND NON-PHARMACOLOGIC THERAPIES TO RELIEVE STRESS AND ANXIETY, AND YOGA IS ONE OPTION FOR WHICH RESULTS ARE PROMISING. THE FOCUS OF THIS REVIEW IS ON THE RESULTS OF HUMAN TRIALS ASSESSING THE ROLE OF YOGA IN IMPROVING THE SIGNS AND SYMPTOMS OF STRESS AND ANXIETY. OF 35 TRIALS ADDRESSING THE EFFECTS OF YOGA ON ANXIETY AND STRESS, 25 NOTED A SIGNIFICANT DECREASE IN STRESS AND/OR ANXIETY SYMPTOMS WHEN A YOGA REGIMEN WAS IMPLEMENTED; HOWEVER, MANY OF THE STUDIES WERE ALSO HINDERED BY LIMITATIONS, SUCH AS SMALL STUDY POPULATIONS, LACK OF RANDOMIZATION, AND LACK OF A CONTROL GROUP. FOURTEEN OF THE 35 STUDIES REPORTED BIOCHEMICAL AND PHYSIOLOGICAL MARKERS OF STRESS AND ANXIETY, BUT YIELDED INCONSISTENT SUPPORT OF YOGA FOR RELIEF OF STRESS AND ANXIETY. EVALUATION OF THE CURRENT PRIMARY LITERATURE IS SUGGESTIVE OF BENEFITS OF YOGA IN RELIEVING STRESS AND ANXIETY, BUT FURTHER INVESTIGATION INTO THIS RELATIONSHIP USING LARGE, WELL-DEFINED POPULATIONS, ADEQUATE CONTROLS, RANDOMIZATION AND LONG DURATION SHOULD BE EXPLORED BEFORE RECOMMENDING YOGA AS A TREATMENT OPTION. 2012 10 2837 30 YOGA'S IMPACT ON RISK AND PROTECTIVE FACTORS FOR DISORDERED EATING: A PILOT PREVENTION TRIAL. YOGA HAS BEEN PROPOSED AS A STRATEGY FOR IMPROVING RISK AND PROTECTIVE FACTORS FOR EATING DISORDERS, BUT FEW PREVENTION TRIALS HAVE BEEN CONDUCTED. THE PURPOSE OF THIS PILOT STUDY WAS TO ASSESS THE FEASIBILITY AND ACCEPTABILITY OF A YOGA SERIES IN FEMALE COLLEGE STUDENTS (N = 52). PARTICIPANTS WERE RANDOMIZED TO A YOGA INTERVENTION (THREE 50-MINUTE YOGA CLASSES/WEEK FOR 10 WEEKS CONDUCTED BY CERTIFIED YOGA TEACHERS WHO RECEIVED A 3-DAY INTENSIVE TRAINING) OR A CONTROL GROUP. RISK AND PROTECTIVE FACTORS, ASSESSED AT BASELINE, 5 AND 10 WEEKS, INCLUDED BODY DISSATISFACTION, NEGATIVE AFFECT, LONELINESS, SELF-COMPASSION, POSITIVE AFFECT, AND MINDFULNESS. MIXED MODELS CONTROLLING FOR BASELINE LEVELS OF OUTCOME VARIABLES WERE RUN. ON AVERAGE, PARTICIPANTS ATTENDED 20 OUT OF 30 YOGA CLASSES, AND THE MAJORITY OF PARTICIPANTS REPORTED HIGH LEVELS OF SATISFACTION WITH THE YOGA SERIES. APPEARANCE ORIENTATION DECREASED AND POSITIVE AFFECT INCREASED IN THE YOGA GROUP RELATIVE TO THE CONTROL GROUP. AFTER CONTROLLING FOR BASELINE LEVELS, THE YOGA GROUP HAD A SIGNIFICANTLY HIGHER POSITIVE AFFECT THAN THE CONTROL GROUP. CHANGES IN OTHER OUTCOMES WERE NOT STATISTICALLY SIGNIFICANT, AS COMPARED TO THE CONTROL CONDITION. FUTURE YOGA RESEARCH DIRECTIONS ARE DISCUSSED INCLUDING EDUCATION ABOUT BODY IMAGE, MEASURE AND SAMPLE SELECTION, AND USE OF AN IMPLEMENTATION SCIENCE FRAMEWORK. 2020 11 2038 28 TELOMERASE ACTIVITY AND CELLULAR AGING MIGHT BE POSITIVELY MODIFIED BY A YOGA-BASED LIFESTYLE INTERVENTION. OBJECTIVES: RECENT STUDIES SHOWED THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING LEVELS OF OXIDATIVE STRESS AND CELLULAR AGING IN OBESE MEN. THE OBJECTIVE OF THIS CASE REPORT WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING THE LEVELS OF BIOCHEMICAL MARKERS OF CELLULAR AGEING, OXIDATIVE STRESS, AND INFLAMMATION AT BASELINE (DAY 0), AT THE END OF ACTIVE INTERVENTION (DAY 10), AND FOLLOW-UP AT DAY 90. DESIGN: SINGLE CASE REPORT FROM A PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN ASSESSING THE LEVEL OF VARIOUS MARKERS OF CELLULAR AGING. SETTING: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING MEDITATION AND YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR MANAGEMENT OF CHRONIC DISEASES. PATIENT: A 31-YEAR-OLD MAN WITH CLASS I OBESITY (BODY-MASS INDEX, 29.5 KG/M(2)) WHO PRESENTED TO THE MEDICINE OUTPATIENT DEPARTMENT AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA, WITH A HISTORY OF FATIGUE, DIFFICULTY LOSING WEIGHT, AND LACK OF MOTIVATION. HE NOTED A MARKED DECREASE IN HIS ENERGY LEVEL, PARTICULARLY IN THE AFTERNOON. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. RESULTS: FROM BASELINE (DAY 0) TO DAY 90, THE ACTIVITY OF TELOMERASE AND LEVELS OF BETA-ENDORPHINS, PLASMA CORTISOL, AND INTERLEUKIN-6 INCREASED, AND A SUSTAINED REDUCTION IN OXIDATIVE STRESS MARKERS, SUCH AS REACTIVE OXYGEN SPECIES AND 8-HYDROXY-2-DEOXY-GUANOSINE LEVELS. CONCLUSIONS: ADOPTING YOGA/MEDITATION-BASED LIFESTYLE MODIFICATION CAUSES REVERSAL OF MARKERS OF AGING, MAINLY OXIDATIVE STRESS, TELOMERASE ACTIVITY, AND OXIDATIVE DNA DAMAGE. THIS MAY NOT ONLY DELAY AGING AND PROLONG A YOUTHFUL HEALTHY LIFE BUT ALSO DELAY OR PREVENT ONSET OF SEVERAL LIFESTYLE-RELATED DISEASES, OF WHICH OXIDATIVE STRESS AND INFLAMMATION ARE THE CHIEF CAUSE. THIS REPORT SUGGESTS THIS SIMPLE LIFESTYLE INTERVENTION MAY BE THERAPEUTIC FOR OXIDATIVE DNA DAMAGE AND OXIDATIVE STRESS. 2015 12 1846 27 QUALITY OF LIFE AND MENTAL HEALTH IN PATIENTS WITH CHRONIC DISEASES WHO REGULARLY PRACTICE YOGA AND THOSE WHO DO NOT: A CASE-CONTROL STUDY. WHILE CLINICAL TRIALS HAVE SHOWN EVIDENCE OF EFFICACY OF YOGA IN DIFFERENT CHRONIC DISEASES, SUBJECTIVE HEALTH BENEFITS ASSOCIATED WITH YOGA PRACTICE UNDER NATURALISTIC CONDITIONS HAVE NOT YET BEEN INVESTIGATED. THE AIM OF THIS STUDY WAS TO INVESTIGATE ASSOCIATIONS OF REGULAR YOGA PRACTICE WITH QUALITY OF LIFE AND MENTAL HEALTH IN PATIENTS WITH CHRONIC DISEASES. USING A CASE-CONTROL DESIGN, PATIENTS WITH CHRONIC DISEASES WHO REGULARLY PRACTICED YOGA WERE SELECTED FROM A LARGE OBSERVATIONAL STUDY AND COMPARED TO CONTROLS WHO DID NOT REGULARLY PRACTICE YOGA AND WHO WERE MATCHED INDIVIDUALLY TO EACH CASE ON GENDER, MAIN DIAGNOSIS, EDUCATION, AND AGE (WITHIN 5 YEARS). PATIENTS' QUALITY OF LIFE (SF-36 QUESTIONNAIRE), MENTAL HEALTH (HOSPITAL ANXIETY AND DEPRESSION SCALE), LIFE SATISFACTION, AND HEALTH SATISFACTION (QUESTIONNAIRE FOR LIFE SATISFACTION) WERE ASSESSED. PATIENTS WHO REGULARLY PRACTICED YOGA (N = 186) HAD A BETTER GENERAL HEALTH STATUS (P = 0.012), A HIGHER PHYSICAL FUNCTIONING (P = 0.001), AND PHYSICAL COMPONENT SCORE (P = 0.029) ON THE SF-36 THAN THOSE WHO DID NOT (N = 186). NO GROUP DIFFERENCES WERE FOUND FOR THE MENTAL SCALES OF THE SF-36, ANXIETY, DEPRESSION, LIFE SATISFACTION, OR HEALTH SATISFACTION. IN CONCLUSION, PRACTICING YOGA UNDER NATURALISTIC CONDITIONS SEEMS TO BE ASSOCIATED WITH INCREASED PHYSICAL HEALTH BUT NOT MENTAL HEALTH IN CHRONICALLY DISEASED PATIENTS. 2013 13 2411 40 YOGA AND IMMUNE SYSTEM FUNCTIONING: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. YOGA IS AN ANCIENT MIND-BODY PRACTICE THAT IS INCREASINGLY RECOGNIZED TO HAVE HEALTH BENEFITS IN A VARIETY OF CLINICAL AND NON-CLINICAL CONDITIONS. THIS SYSTEMATIC REVIEW SUMMARIZES THE FINDINGS OF RANDOMIZED CONTROLLED TRIALS EXAMINING THE EFFECTS OF YOGA ON IMMUNE SYSTEM FUNCTIONING WHICH IS IMPERATIVE TO JUSTIFY ITS APPLICATION IN THE CLINIC. FIFTEEN RCTS WERE ELIGIBLE FOR THE REVIEW. EVEN THOUGH THE EXISTING EVIDENCE IS NOT ENTIRELY CONSISTENT, A GENERAL PATTERN EMERGED SUGGESTING THAT YOGA CAN DOWNREGULATE PRO-INFLAMMATORY MARKERS. IN PARTICULAR, THE QUALITATIVE EVALUATION OF RCTS REVEALED DECREASES IN IL-1BETA, AS WELL AS INDICATIONS FOR REDUCTIONS IN IL-6 AND TNF-ALPHA. THESE RESULTS IMPLY THAT YOGA MAY BE IMPLEMENTED AS A COMPLEMENTARY INTERVENTION FOR POPULATIONS AT RISK OR ALREADY SUFFERING FROM DISEASES WITH AN INFLAMMATORY COMPONENT. BEYOND THIS, YOGA PRACTICE MAY EXERT FURTHER BENEFICIAL EFFECTS BY ENHANCING CELL-MEDIATED AND MUCOSAL IMMUNITY. IT IS HYPOTHESIZED THAT LONGER TIME SPANS OF YOGA PRACTICE ARE REQUIRED TO ACHIEVE CONSISTENT EFFECTS ESPECIALLY ON CIRCULATING INFLAMMATORY MARKERS. OVERALL, THIS FIELD OF INVESTIGATION IS STILL YOUNG, HENCE THE CURRENT BODY OF EVIDENCE IS SMALL AND FOR MOST IMMUNE PARAMETERS, MORE RESEARCH IS REQUIRED TO DRAW DISTINCT CONCLUSIONS. 2018 14 2834 31 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 15 1854 36 RANDOMISED CONTROLLED TRIAL OF A 12 WEEK YOGA INTERVENTION ON NEGATIVE AFFECTIVE STATES, CARDIOVASCULAR AND COGNITIVE FUNCTION IN POST-CARDIAC REHABILITATION PATIENTS. BACKGROUND: NEGATIVE AFFECTIVE STATES SUCH AS ANXIETY, DEPRESSION AND STRESS ARE SIGNIFICANT RISK FACTORS FOR CARDIOVASCULAR DISEASE, PARTICULARLY IN CARDIAC AND POST-CARDIAC REHABILITATION POPULATIONS.YOGA IS A BALANCED PRACTICE OF PHYSICAL EXERCISE, BREATHING CONTROL AND MEDITATION THAT CAN REDUCE PSYCHOSOCIAL SYMPTOMS AS WELL AS IMPROVE CARDIOVASCULAR AND COGNITIVE FUNCTION. IT HAS THE POTENTIAL TO POSITIVELY AFFECT MULTIPLE DISEASE PATHWAYS AND MAY PROVE TO BE A PRACTICAL ADJUNCT TO CARDIAC REHABILITATION IN FURTHER REDUCING CARDIAC RISK FACTORS AS WELL AS IMPROVING SELF-EFFICACY AND POST-CARDIAC REHABILITATION ADHERENCE TO HEALTHY LIFESTYLE BEHAVIOURS. METHOD AND DESIGN: THIS IS A PARALLEL ARM, MULTI-CENTRE, RANDOMISED CONTROLLED TRIAL THAT WILL ASSESS THE OUTCOMES OF POST- PHASE 2 CARDIAC REHABILITATION PATIENTS ASSIGNED TO A YOGA INTERVENTION IN COMPARISON TO A NO-TREATMENT WAIT-LIST CONTROL GROUP. PARTICIPANTS RANDOMISED TO THE YOGA GROUP WILL ENGAGE IN A 12 WEEK YOGA PROGRAM COMPRISING OF TWO GROUP BASED SESSIONS AND ONE SELF-ADMINISTERED HOME SESSION EACH WEEK. GROUP BASED SESSIONS WILL BE LED BY AN EXPERIENCED YOGA INSTRUCTOR. THIS WILL INVOLVE TEACHING BEGINNER STUDENTS A HATHA YOGA SEQUENCE THAT INCORPORATES ASANA (POSES AND POSTURES), PRANAYAMA (BREATHING CONTROL) AND MEDITATION. THE PRIMARY OUTCOMES OF THIS STUDY ARE NEGATIVE AFFECTIVE STATES OF ANXIETY, DEPRESSION AND STRESS ASSESSED USING THE DEPRESSION ANXIETY STRESS SCALE. SECONDARY OUTCOMES INCLUDE MEASURES OF QUALITY OF LIFE, AND CARDIOVASCULAR AND COGNITIVE FUNCTION. THE CARDIOVASCULAR OUTCOMES WILL INCLUDE BLOOD PRESSURE, HEART RATE, HEART RATE VARIABILITY, PULSE WAVE VELOCITY, CAROTID INTIMA MEDIA THICKNESS MEASUREMENTS, LIPID/GLUCOSE PROFILES AND C-REACTIVE PROTEIN ASSAYS. ASSESSMENTS WILL BE CONDUCTED PRIOR TO (WEEK 0), MID-WAY THROUGH (WEEK 6) AND FOLLOWING THE INTERVENTION PERIOD (WEEK 12) AS WELL AS AT A FOUR WEEK FOLLOW-UP (WEEK 16). DISCUSSION: THIS STUDY WILL DETERMINE THE EFFECT OF YOGA PRACTICE ON NEGATIVE AFFECTIVE STATES, CARDIOVASCULAR AND COGNITIVE FUNCTION IN POST-PHASE 2 CARDIAC REHABILITATION PATIENTS. THE FINDINGS MAY PROVIDE EVIDENCE TO INCORPORATE YOGA INTO STANDARDISED CARDIAC REHABILITATION PROGRAMS AS A PRACTICAL ADJUNCT TO IMPROVE THE MANAGEMENT OF PSYCHOSOCIAL SYMPTOMS ASSOCIATED WITH CARDIOVASCULAR EVENTS IN ADDITION TO IMPROVING PATIENTS' COGNITIVE AND CARDIOVASCULAR FUNCTIONS. TRIAL REGISTRATION: ACTRN12612000358842. 2014 16 2458 34 YOGA AS A COMPLEMENTARY TREATMENT OF DEPRESSION: EFFECTS OF TRAITS AND MOODS ON TREATMENT OUTCOME. PRELIMINARY FINDINGS SUPPORT THE POTENTIAL OF YOGA AS A COMPLEMENTARY TREATMENT OF DEPRESSED PATIENTS WHO ARE TAKING ANTI-DEPRESSANT MEDICATIONS BUT WHO ARE ONLY IN PARTIAL REMISSION. THE PURPOSE OF THIS ARTICLE IS TO PRESENT FURTHER DATA ON THE INTERVENTION, FOCUSING ON INDIVIDUAL DIFFERENCES IN PSYCHOLOGICAL, EMOTIONAL AND BIOLOGICAL PROCESSES AFFECTING TREATMENT OUTCOME. TWENTY-SEVEN WOMEN AND 10 MEN WERE ENROLLED IN THE STUDY, OF WHOM 17 COMPLETED THE INTERVENTION AND PRE- AND POST-INTERVENTION ASSESSMENT DATA. THE INTERVENTION CONSISTED OF 20 CLASSES LED BY SENIOR IYENGAR YOGA TEACHERS, IN THREE COURSES OF 20 YOGA CLASSES EACH. ALL PARTICIPANTS WERE DIAGNOSED WITH UNIPOLAR MAJOR DEPRESSION IN PARTIAL REMISSION. PSYCHOLOGICAL AND BIOLOGICAL CHARACTERISTICS WERE ASSESSED PRE- AND POST-INTERVENTION, AND PARTICIPANTS RATED THEIR MOOD STATES BEFORE AND AFTER EACH CLASS. SIGNIFICANT REDUCTIONS WERE SHOWN FOR DEPRESSION, ANGER, ANXIETY, NEUROTIC SYMPTOMS AND LOW FREQUENCY HEART RATE VARIABILITY IN THE 17 COMPLETERS. ELEVEN OUT OF THESE COMPLETERS ACHIEVED REMISSION LEVELS POST-INTERVENTION. PARTICIPANTS WHO REMITTED DIFFERED FROM THE NON-REMITTERS AT INTAKE ON SEVERAL TRAITS AND ON PHYSIOLOGICAL MEASURES INDICATIVE OF A GREATER CAPACITY FOR EMOTIONAL REGULATION. MOODS IMPROVED FROM BEFORE TO AFTER THE YOGA CLASSES. YOGA APPEARS TO BE A PROMISING INTERVENTION FOR DEPRESSION; IT IS COST-EFFECTIVE AND EASY TO IMPLEMENT. IT PRODUCES MANY BENEFICIAL EMOTIONAL, PSYCHOLOGICAL AND BIOLOGICAL EFFECTS, AS SUPPORTED BY OBSERVATIONS IN THIS STUDY. THE PHYSIOLOGICAL METHODS ARE ESPECIALLY USEFUL AS THEY PROVIDE OBJECTIVE MARKERS OF THE PROCESSES AND EFFECTIVENESS OF TREATMENT. THESE OBSERVATIONS MAY HELP GUIDE FURTHER CLINICAL APPLICATION OF YOGA IN DEPRESSION AND OTHER MENTAL HEALTH DISORDERS, AND FUTURE RESEARCH ON THE PROCESSES AND MECHANISMS. 2007 17 549 20 CONTEXTUALIZING THE EFFECTS OF YOGA THERAPY ON DIABETES MANAGEMENT: A REVIEW OF THE SOCIAL DETERMINANTS OF PHYSICAL ACTIVITY. THIS ARTICLE PROVIDES A REVIEW OF LITERATURE BOTH TO IDENTIFY THE EFFECTS OF YOGA-BASED THERAPY ON THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS AND TO EXAMINE THE SOCIAL CONTEXT OF PHYSICAL ACTIVITY. FINDINGS FROM THE REVIEW INDICATE THAT YOGA HAS A POSITIVE SHORT-TERM EFFECT ON MULTIPLE DIABETES-RELATED OUTCOMES; HOWEVER, LONG-TERM EFFECTS OF YOGA THERAPY ON DIABETES MANAGEMENT REMAIN UNCLEAR. THE CONTEXT OF THE SOCIAL ENVIRONMENT, INCLUDING INTERPERSONAL RELATIONSHIPS, COMMUNITY CHARACTERISTICS, AND DISCRIMINATION, INFLUENCES THE ADOPTION AND MAINTENANCE OF HEALTH BEHAVIORS SUCH AS PHYSICAL ACTIVITY, INCLUDING YOGA PRACTICE. FURTHER RESEARCH IS NECESSARY TO DETERMINE THE EXTENT OF THIS INFLUENCE. 2008 18 1373 31 IMPACT OF A YOGA INTERVENTION ON PHYSICAL ACTIVITY, SELF-EFFICACY, AND MOTIVATION IN WOMEN WITH PTSD SYMPTOMS. BACKGROUND: STUDIES USING YOGA HAVE DEMONSTRATED INITIAL EFFICACY FOR TREATING SYMPTOMS ACROSS ANXIETY DISORDERS, INCLUDING POSTTRAUMATIC STRESS DISORDER. OBJECTIVE: UNDERSTANDING HOW INTERVENTIONS INFLUENCE PARTICIPANTS' PHYSICAL ACTIVITY AND WHAT DETERMINANTS AFFECT CONTINUED PHYSICAL ACTIVITY BEHAVIOR CHANGE IS IMPORTANT BECAUSE MAINTENANCE OF THE BEHAVIOR MAY BE CRITICAL TO CONTINUED MENTAL HEALTH GAINS AND SYMPTOM REDUCTION. METHODS: THIS STUDY INVESTIGATED CHANGE IN PHYSICAL ACTIVITY AND POSSIBLE PSYCHOLOGICAL MECHANISMS OF PHYSICAL ACTIVITY BEHAVIOR CHANGE, INCLUDING SELF-EFFICACY AND REGULATORY MOTIVATION, IN A RANDOMIZED CONTROLLED TRIAL OF YOGA FOR WOMEN WITH POST-TRAUMATIC STRESS DISORDER SYMPTOMS (N=38). RESULTS: GROWTH CURVE MODELING RESULTS SHOWED NO SIGNIFICANT CHANGES IN PHYSICAL ACTIVITY OR SELF-EFFICACY FOR EITHER GROUP, WHEREAS EXTERNAL MOTIVATION DECREASED SIGNIFICANTLY IN THE YOGA GROUP BUT NOT IN THE CONTROL GROUP. CONCLUSIONS: INVESTIGATORS OF FUTURE YOGA INTERVENTIONS MAY WANT TO FOCUS ON INCREASING SELF-EFFICACY AND INTERNAL REGULATORY MOTIVATION, SO THAT PHYSICAL ACTIVITY AND RESULTANT SYMPTOM RELIEF CAN BE MAINTAINED. 2015 19 2847 42 YOGA, MEDITATION AND MIND-BODY HEALTH: INCREASED BDNF, CORTISOL AWAKENING RESPONSE, AND ALTERED INFLAMMATORY MARKER EXPRESSION AFTER A 3-MONTH YOGA AND MEDITATION RETREAT. THIRTY-EIGHT INDIVIDUALS (MEAN AGE: 34.8 YEARS OLD) PARTICIPATING IN A 3-MONTH YOGA AND MEDITATION RETREAT WERE ASSESSED BEFORE AND AFTER THE INTERVENTION FOR PSYCHOMETRIC MEASURES, BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF), CIRCADIAN SALIVARY CORTISOL LEVELS, AND PRO- AND ANTI-INFLAMMATORY CYTOKINES. PARTICIPATION IN THE RETREAT WAS FOUND TO BE ASSOCIATED WITH DECREASES IN SELF-REPORTED ANXIETY AND DEPRESSION AS WELL AS INCREASES IN MINDFULNESS. AS HYPOTHESIZED, INCREASES IN THE PLASMA LEVELS OF BDNF AND INCREASES IN THE MAGNITUDE OF THE CORTISOL AWAKENING RESPONSE (CAR) WERE ALSO OBSERVED. THE NORMALIZED CHANGE IN BDNF LEVELS WAS INVERSELY CORRELATED WITH BSI-18 ANXIETY SCORES AT BOTH THE PRE-RETREAT (R = 0.40, P < 0.05) AND POST-RETREAT (R = 0.52, P < 0.005) SUCH THAT THOSE WITH GREATER ANXIETY SCORES TENDED TO EXHIBIT SMALLER PRE- TO POST-RETREAT INCREASES IN PLASMA BDNF LEVELS. IN LINE WITH A HYPOTHESIZED DECREASE IN INFLAMMATORY PROCESSES RESULTING FROM THE YOGA AND MEDITATION PRACTICES, WE FOUND THAT THE PLASMA LEVEL OF THE ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 WAS INCREASED AND THE PRO-INFLAMMATORY CYTOKINE INTERLEUKIN-12 WAS REDUCED AFTER THE RETREAT. CONTRARY TO OUR INITIAL HYPOTHESES, PLASMA LEVELS OF OTHER PRO-INFLAMMATORY CYTOKINES, INCLUDING INTERFERON GAMMA (IFN-GAMMA), TUMOR NECROSIS FACTOR (TNF-ALPHA), INTERLEUKIN-1BETA (IL-1BETA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-8 (IL-8) WERE INCREASED AFTER THE RETREAT. GIVEN EVIDENCE FROM PREVIOUS STUDIES OF THE POSITIVE EFFECTS OF MEDITATIVE PRACTICES ON MENTAL FITNESS, AUTONOMIC HOMEOSTASIS AND INFLAMMATORY STATUS, WE HYPOTHESIZE THAT THESE FINDINGS ARE RELATED TO THE MEDITATIVE PRACTICES THROUGHOUT THE RETREAT; HOWEVER, SOME OF THE OBSERVED CHANGES MAY ALSO BE RELATED TO OTHER ASPECTS OF THE RETREAT SUCH AS PHYSICAL EXERCISE-RELATED COMPONENTS OF THE YOGA PRACTICE AND DIET. WE HYPOTHESIZE THAT THE PATTERNS OF CHANGE OBSERVED HERE REFLECT MIND-BODY INTEGRATION AND WELL-BEING. THE INCREASED BDNF LEVELS OBSERVED IS A POTENTIAL MEDIATOR BETWEEN MEDITATIVE PRACTICES AND BRAIN HEALTH, THE INCREASED CAR IS LIKELY A REFLECTION OF INCREASED DYNAMIC PHYSIOLOGICAL AROUSAL, AND THE RELATIONSHIP OF THE DUAL ENHANCEMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINE CHANGES TO HEALTHY IMMUNOLOGIC FUNCTIONING IS DISCUSSED. 2017 20 2822 39 YOGA V. HEALTH EDUCATION FOR ATTENTIONAL PROCESSES RELEVANT TO MAJOR DEPRESSIVE DISORDER. OBJECTIVES: RESEARCH HAS SHOWN THAT YOGA MAY BE AN EFFECTIVE ADJUNCTIVE TREATMENT FOR PERSISTENT DEPRESSION, THE BENEFITS OF WHICH MAY ACCUMULATE OVER TIME. THE OBJECTIVES OF THIS STUDY WERE TO EVALUATE THE FOLLOWING IN A SAMPLE OF PERSISTENTLY DEPRESSED INDIVIDUALS: WHETHER YOGA INCREASES MINDFULNESS AND WHETHER YOGA ATTENUATES RUMINATION. RUMINATION AND MINDFULNESS BOTH REPRESENT ATTENTIONAL PROCESSES RELEVANT FOR ONSET AND MAINTENANCE OF DEPRESSIVE EPISODES. METHODS: ONE-HUNDRED-TEN INDIVIDUALS WHO WERE PERSISTENTLY DEPRESSED DESPITE ONGOING USE OF PHARMACOLOGICAL TREATMENT WERE RECRUITED INTO AN RCT COMPARING YOGA WITH A HEALTH EDUCATION CLASS. MINDFULNESS AND RUMINATION WERE ASSESSED AT BASELINE AND ACROSS 3 TIME POINTS DURING THE TEN-WEEK INTERVENTION. RESULTS: FINDINGS DEMONSTRATE THAT, COMPARED TO HEALTH EDUCATION, YOGA WAS ASSOCIATED WITH HIGHER MEAN LEVELS OF THE OBSERVE FACET OF MINDFULNESS RELATIVE TO THE CONTROL GROUP DURING THE INTERVENTION PERIOD (P =.004, D =0.38), AND THAT YOGA WAS ASSOCIATED WITH A FASTER RATE OF INCREASE IN LEVELS OF ACTING WITH AWARENESS OVER THE INTERVENTION PERIOD (P= .03, F(2) =0.027). THERE WERE NO DIFFERENCES BETWEEN INTERVENTION GROUPS WITH RESPECT TO RUMINATION. CONCLUSIONS: RESULTS SUGGEST A SMALL EFFECT OF YOGA ON COMPONENTS OF MINDFULNESS DURING A 10-WEEK INTERVENTION PERIOD. PREVIOUS RESEARCH SUGGESTS THAT CONTINUED ASSESSMENT AFTER THE INITIAL 10 WEEKS MAY REVEAL CONTINUED IMPROVEMENT. FUTURE RESEARCH MAY ALSO EXAMINE MODERATORS OF THE IMPACT OF YOGA ON MINDFULNESS AND RUMINATION, INCLUDING CLINICAL FACTORS SUCH AS DEPRESSION SEVERITY OR DEPRESSION CHRONICITY, OR DEMOGRAPHIC FACTORS SUCH AS AGE. 2021